CareDx Inc (CDNA) Surpasses Revenue Expectations Despite Net Loss Expansion in 2023 [Yahoo! Finance]
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Yahoo! Finance
Testing Services Growth : Achieved a 4% sequential increase in Testing Services patient results in Q4 2023, with approximately 39,900 results delivered. Profitability Measures : Collected $17 million in cash over its revenue in 2023, marking the fifth consecutive quarter of collections exceeding 100% of Testing Services revenue. Net Loss : Reported a significant net loss of $118.1 million in Q4 2023, largely due to a $96.3 million accrual for patent litigation damages. Share Buyback : Repurchased 2.9 million shares of common stock for $27.5 million under the share buyback program in 2023. 2024 Guidance : Projected revenue for 2024 is expected to be between $260 million and $274 million. Warning! GuruFocus has detected 5 Warning Signs with CDNA. On February 28, 2024, CareDx Inc ( NASDAQ:CDNA ), a leading precision medicine solutions company, released its 8-K filing , announcing financial results for the fourth quarter and full year ended December 31, 2023. The company, whi
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- Cytonus Therapeutics Expands C-suite as it Transitions to a Clinical Stage Company [Yahoo! Finance]Yahoo! Finance
- CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)Business Wire
- CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last? [Yahoo! Finance]Yahoo! Finance
- CareDx, Inc (NASDAQ: CDNA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $15.00 price target on the stock.MarketBeat
CDNA
Earnings
- 2/28/24 - Beat
CDNA
Sec Filings
- 4/25/24 - Form S-8
- 4/25/24 - Form 3
- 4/22/24 - Form 4
- CDNA's page on the SEC website